Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01234207 · ClinicalTrials.gov registry record · NA

Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle

A NA study of Presbyopia, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT01234207 is a NA study of Presbyopia that has completed, run by University of California, Berkeley. The registered enrollment target is 95 participants, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01234207, a NA study of Presbyopia, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare objective clinical measures of visual performance and subjective measures of satisfaction and preference between standard progressive addition lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL spectacle.

Conditions Studied

Interventions

  • DEVICE Standard, non-free-form, non-customized PAL spectacles
  • DEVICE Individually customized free-form surfaced PAL spectacles

Study Locations (1)

California

  • Clinical Research Center, School of Optometry, University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2009-02
Est. Completion 2009-10
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT01234207

The ClinicalTrials.gov registry entry for NCT01234207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (65% lower). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Standard, non-free-form, non-customized PAL spectacles is the first listed.

NCT01234207 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01234207 about?

NCT01234207 is a clinical study titled "Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle". The purpose of this study was to compare objective clinical measures of visual performance and subjective measures of satisfaction and preference between standard progressive addition lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL spectacle.

What is the current status of trial NCT01234207?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2009-02. Estimated completion is 2009-10.

What conditions does trial NCT01234207 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT01234207?

The interventions under investigation include: Standard, non-free-form, non-customized PAL spectacles (DEVICE), Individually customized free-form surfaced PAL spectacles (DEVICE).

Who is sponsoring clinical trial NCT01234207?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01234207 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.